Table 2.

Patient outcomes.

Patient outcomes
RECIST best response:
Complete response	0/54 (0%; 95% CI, 0.0%–6.6%)
Partial response	6/54 (11.1%; 95% CI, 4.2%–22.6%)
Stable disease	33/54 (61.1%; 95% CI, 46.9%–74.1%)
Progressive disease	9/54 (16.7%; 95% CI, 7.9%–29.3%)
6-month PFS	49.3% (95% CI, 36.2%–67.3%)
Duration of response: median (range)	16 (4–78) months